FWIA
ISEE

Fort Washington Investment Advisors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Fort Washington Investment Advisors’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-5,743
Closed -$224K – 440
2014
Q3 		$224K Sell
5,743
-127,586
-96% -$5.01M ﹤0.01% 411
2014
Q2 		$5.64M Buy
133,329
+27,699
+26% +$1.02M 0.11% 152
2014
Q1 		$3.77M Buy
+105,630
New +$3.56M 0.08% 160

Other funds holding ISEE

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fort Washington Investment Advisors's ISEE Position: Q4 2014 in Review

Fort Washington Investment Advisors sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2014, closing a stake of 5,743 shares — an estimated $224K sold.

Fort Washington Investment Advisors first reported a position in ISEE in Q1 2014 and held it in 3 quarters. The position peaked at $5.64M in Q2 2014. 116 funds tracked by Wall St. Rank hold ISEE as of Q4 2014.

  • Fort Washington Investment Advisors reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
  • Fort Washington Investment Advisors sold 5,743 IVERIC bio, Inc. Common Stock shares in Q4 2014, an estimated $224K.
  • Fort Washington Investment Advisors first reported a position in IVERIC bio, Inc. Common Stock in Q1 2014 and held it in 3 quarters.
  • Fort Washington Investment Advisors's IVERIC bio, Inc. Common Stock position peaked at $5.64M in Q2 2014.
  • 116 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2014.

Based on Fort Washington Investment Advisors's 13F filing for Q4 2014, filed 12 Feb 2015.